References
- Dougherty T J, Marcus SL. Photodynamic therapy. Eur J Cancer 1992; 28A: 1734–1742
- Iversen OH. Hairless mouse skin in two-stage chemical carcinogenesis. Virchows Arch B Cell Pathol 1982; 38: 263–272
- Azzi V, Notter D, Merlin J L, . Composition and spectral characteristics, cytotoxicity and quantum yield of singlet oxygen formation of haematoporphyrin derivative preparation. Photodynamic therapy and biomedical lasers, P Spinelli, M Dalfante, R Marchesini, et al. Excerpta medica Publ, Amsterdam 1992; 715–719
- Bossu E, A'Amar O, Parache RM, Notter D, Labrude P, Vigneron C, Guillemin F. Determination of the maximal tumor / normal skin ratio after HpD or m-THPC administration in hairless mouse (SKH-1) by fluorescence spectroscopy, a non invasive method. Anti-Cancer Drugs 1997; 8: 67–72
- Guillemin F, A'Amar O, Rezzoug H, et al. Optical instrumentation suitable for a real time dosimetry during photodynamic therapy. Prog Biomed Optics, Proceedings of Optoelectronic Research and Technologies 1995; 2627: 92–99
- Morlet L, Vonarx-Coinsmann V, Lenz P, et al. Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. J Photochem Photobiol B : Biology 1995; 28: 25–32
- Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy : a comparison of its photobiological properties with those of two other photosensitizers. Hit J Cancer 1994; 57: 883–888